Gene therapy developers can benefit from orphan drug and rare pediatric disease designations
webmaster2024-07-13T13:30:32+00:00Providing an overview of the submissions process and examples of U.S. Food and Drug Administration (FDA) applications for Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD), a new article can help developers of gene therapies for rare genetic diseases...